Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 North Greene Street, Baltimore, MD 21201, USA.
J Mol Biol. 2012 Jul 13;420(3):164-75. doi: 10.1016/j.jmb.2012.04.028. Epub 2012 May 2.
The mammalian repair protein MBD4 (methyl-CpG-binding domain IV) excises thymine from mutagenic G·T mispairs generated by deamination of 5-methylcytosine (mC), and downstream base excision repair proteins restore a G·C pair. MBD4 is also implicated in active DNA demethylation by initiating base excision repair of G·T mispairs generated by a deaminase enzyme. The question of how mismatch glycosylases attain specificity for excising thymine from G·T, but not A·T, pairs remains largely unresolved. Here, we report a crystal structure of the glycosylase domain of human MBD4 (residues 427-580) bound to DNA containing an abasic nucleotide paired with guanine, providing a glimpse of the enzyme-product complex. The mismatched guanine remains intrahelical, nestled into a recognition pocket. MBD4 provides selective interactions with the mismatched guanine (N1H, N2H(2)) that are not compatible with adenine, which likely confer mismatch specificity. The structure reveals no interactions that would be expected to provide the MBD4 glycosylase domain with specificity for acting at CpG sites. Accordingly, we find modest 1.5- to 2.7-fold reductions in G·T activity upon altering the CpG context. In contrast, 37- to 580-fold effects were observed previously for thymine DNA glycosylase. These findings suggest that specificity of MBD4 for acting at CpG sites depends largely on its methyl-CpG-binding domain, which binds preferably to G·T mispairs in a methylated CpG site. MBD4 glycosylase cannot excise 5-formylcytosine (fC) or 5-carboxylcytosine (caC), intermediates in a Tet (ten eleven translocation)-initiated DNA demethylation pathway. Our structure suggests that MBD4 does not provide the electrostatic interactions needed to excise these oxidized forms of mC.
哺乳动物修复蛋白 MBD4(甲基-CpG 结合域 IV)从 5-甲基胞嘧啶(mC)脱氨基产生的诱变 G·T 错配中切除胸腺嘧啶,下游碱基切除修复蛋白将其恢复为 G·C 对。MBD4 还通过启动脱氨酶产生的 G·T 错配的碱基切除修复来参与主动 DNA 去甲基化。配对,但不是 A·T,配对的错配糖苷酶如何获得特异性切除胸腺嘧啶的问题在很大程度上仍未得到解决。在这里,我们报告了与人 MBD4 的糖苷酶结构域(残基 427-580)与含有与鸟嘌呤配对的无碱基核苷酸的 DNA 结合的晶体结构,提供了酶-产物复合物的一瞥。不匹配的鸟嘌呤仍然在螺旋内,嵌套在识别口袋中。MBD4 提供与不匹配的鸟嘌呤(N1H、N2H(2))的选择性相互作用,这些相互作用与腺嘌呤不兼容,这可能赋予错配特异性。该结构没有揭示出预期赋予 MBD4 糖苷酶结构域在 CpG 位点起作用的特异性的相互作用。因此,我们发现改变 CpG 背景后,G·T 活性降低 1.5 到 2.7 倍。相比之下,先前观察到胸腺嘧啶 DNA 糖苷酶的活性降低 37 到 580 倍。这些发现表明,MBD4 对 CpG 位点的作用特异性在很大程度上取决于其甲基-CpG 结合域,该结合域在甲基化的 CpG 位点中优先与 G·T 错配结合。MBD4 糖苷酶不能切除 5-甲酰胞嘧啶(fC)或 5-羧基胞嘧啶(caC),这是 Tet(ten eleven translocation)启动的 DNA 去甲基化途径中的中间产物。我们的结构表明,MBD4 不能提供切除这些 mC 氧化形式所需的静电相互作用。